nyse:abbv
|
516087
|
Apr 21st, 2024 12:00AM
|
ZELTIQ
|
11K
|
109.00
|
Open
|
|
Apr 21st, 2024 03:31AM
|
Apr 21st, 2024 03:31AM
|
CoolSculpting is now part of the Allergan PLC portfolio. Allergan plc (NYSE: AGN) is a bold, global pharmaceutical company and a leader in a new industry model – Growth Pharma. Allergan is focused on developing, manufacturing and commercializing branded pharmaceuticals and biologic products for patients around the world.
Allergan markets a portfolio of best-in-class products that provide novel treatments for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women's health, urology, anti-infective and cardiovascular therapeutic categories. With commercial operations in approximately 100 countries, Allergan is committed to working with physicians, healthcare providers and patients to deliver innovative and meaningful treatments that help people around the world live longer, healthier lives.
|
Open
|
CoolSculpting®
|
Open
|
4410 Rosewood Drive
|
Pleasanton
|
CA
|
US
|
94588
|
|
AbbVie
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:abbv
|
1304385
|
Apr 21st, 2024 12:00AM
|
AbbVie
|
1.3M
|
52488
|
Open
|
|
Apr 21st, 2024 03:31AM
|
Apr 21st, 2024 03:31AM
|
AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need.
Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.
|
Open
|
Biopharmaceutical, Biotechnology, Innovation, Research and Development, Manufacturing, Biotherapeutics, Oncology, Immunology, Virology, Neuroscience, Womens Health, Aesthetics, and Eye Care
|
Open
|
1 Waukegan Road
|
North Chicago
|
Illinois
|
US
|
60064
|
|
AbbVie
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:abbv
|
4832
|
Apr 21st, 2024 12:00AM
|
Allergan
|
689K
|
12432
|
Open
|
|
Apr 21st, 2024 03:31AM
|
Apr 21st, 2024 03:31AM
|
Allergan is now part of AbbVie.
AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio.
For more information about AbbVie, please visit us at www.abbvie.com. Follow @AbbVie on LinkedIn for future updates.
|
Open
|
|
Open
|
Allergan plc
|
Dublin
|
Coolock
|
IE
|
D17 E400
|
|
AbbVie
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:abbv
|
516087
|
Apr 20th, 2024 12:00AM
|
ZELTIQ
|
11K
|
109.00
|
Open
|
|
Apr 20th, 2024 12:41AM
|
Apr 20th, 2024 05:53PM
|
CoolSculpting is now part of the Allergan PLC portfolio. Allergan plc (NYSE: AGN) is a bold, global pharmaceutical company and a leader in a new industry model – Growth Pharma. Allergan is focused on developing, manufacturing and commercializing branded pharmaceuticals and biologic products for patients around the world.
Allergan markets a portfolio of best-in-class products that provide novel treatments for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women's health, urology, anti-infective and cardiovascular therapeutic categories. With commercial operations in approximately 100 countries, Allergan is committed to working with physicians, healthcare providers and patients to deliver innovative and meaningful treatments that help people around the world live longer, healthier lives.
|
Open
|
CoolSculpting®
|
Open
|
4410 Rosewood Drive
|
Pleasanton
|
CA
|
US
|
94588
|
|
AbbVie
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:abbv
|
1304385
|
Apr 20th, 2024 12:00AM
|
AbbVie
|
1.3M
|
52488
|
Open
|
|
Apr 20th, 2024 12:41AM
|
Apr 20th, 2024 05:53PM
|
AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need.
Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.
|
Open
|
Biopharmaceutical, Biotechnology, Innovation, Research and Development, Manufacturing, Biotherapeutics, Oncology, Immunology, Virology, Neuroscience, Womens Health, Aesthetics, and Eye Care
|
Open
|
1 Waukegan Road
|
North Chicago
|
Illinois
|
US
|
60064
|
|
AbbVie
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:abbv
|
4832
|
Apr 20th, 2024 12:00AM
|
Allergan
|
689K
|
12431
|
Open
|
|
Apr 20th, 2024 12:41AM
|
Apr 20th, 2024 05:53PM
|
Allergan is now part of AbbVie.
AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio.
For more information about AbbVie, please visit us at www.abbvie.com. Follow @AbbVie on LinkedIn for future updates.
|
Open
|
|
Open
|
Allergan plc
|
Dublin
|
Coolock
|
IE
|
D17 E400
|
|
AbbVie
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:abbv
|
516087
|
Apr 19th, 2024 12:00AM
|
ZELTIQ
|
11K
|
109.00
|
Open
|
|
Apr 19th, 2024 04:54AM
|
Apr 19th, 2024 04:54AM
|
CoolSculpting is now part of the Allergan PLC portfolio. Allergan plc (NYSE: AGN) is a bold, global pharmaceutical company and a leader in a new industry model – Growth Pharma. Allergan is focused on developing, manufacturing and commercializing branded pharmaceuticals and biologic products for patients around the world.
Allergan markets a portfolio of best-in-class products that provide novel treatments for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women's health, urology, anti-infective and cardiovascular therapeutic categories. With commercial operations in approximately 100 countries, Allergan is committed to working with physicians, healthcare providers and patients to deliver innovative and meaningful treatments that help people around the world live longer, healthier lives.
|
Open
|
CoolSculpting®
|
Open
|
4410 Rosewood Drive
|
Pleasanton
|
CA
|
US
|
94588
|
|
AbbVie
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:abbv
|
4832
|
Apr 19th, 2024 12:00AM
|
Allergan
|
688K
|
12437
|
Open
|
|
Apr 19th, 2024 04:54AM
|
Apr 19th, 2024 04:54AM
|
Allergan is now part of AbbVie.
AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio.
For more information about AbbVie, please visit us at www.abbvie.com. Follow @AbbVie on LinkedIn for future updates.
|
Open
|
|
Open
|
Allergan plc
|
Dublin
|
Coolock
|
IE
|
D17 E400
|
|
AbbVie
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:abbv
|
1304385
|
Apr 19th, 2024 12:00AM
|
AbbVie
|
1.3M
|
52525
|
Open
|
|
Apr 19th, 2024 04:54AM
|
Apr 19th, 2024 04:54AM
|
AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need.
Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.
|
Open
|
Biopharmaceutical, Biotechnology, Innovation, Research and Development, Manufacturing, Biotherapeutics, Oncology, Immunology, Virology, Neuroscience, Womens Health, Aesthetics, and Eye Care
|
Open
|
1 Waukegan Road
|
North Chicago
|
Illinois
|
US
|
60064
|
|
AbbVie
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:abbv
|
516087
|
Apr 18th, 2024 12:00AM
|
ZELTIQ
|
11K
|
109.00
|
Open
|
|
Apr 18th, 2024 01:33AM
|
Apr 18th, 2024 07:13PM
|
CoolSculpting is now part of the Allergan PLC portfolio. Allergan plc (NYSE: AGN) is a bold, global pharmaceutical company and a leader in a new industry model – Growth Pharma. Allergan is focused on developing, manufacturing and commercializing branded pharmaceuticals and biologic products for patients around the world.
Allergan markets a portfolio of best-in-class products that provide novel treatments for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women's health, urology, anti-infective and cardiovascular therapeutic categories. With commercial operations in approximately 100 countries, Allergan is committed to working with physicians, healthcare providers and patients to deliver innovative and meaningful treatments that help people around the world live longer, healthier lives.
|
Open
|
CoolSculpting®
|
Open
|
4410 Rosewood Drive
|
Pleasanton
|
CA
|
US
|
94588
|
|
AbbVie
|
Health Care
|
Pharmaceuticals & Biotechnology
|